Angelos Katramados is a Neurology physician. OpenAlex indexes 50 publications with 895 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd
Department Of Neurology K-11
Detroit, MI 482022608
Telephone
313-916-9107Registry record last updated 7 Nov 2018.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
68.3%Other antiepileptics20.2%Levetiracetam44%Topiramate40%Vimpat15%Part D<11 patientsCalcitonin gene-related peptide (CGRP) antagonists18.3%Emgality Pen62%Aimovig Autoinjector39%Part D<11 patients+ 4 more classes in this area
Cardiovascular
15.7%Statin11.5%Atorvastatin Calcium100%Part D≥15 patientsCholesterol absorption inhibitor4.2%Ezetimibe100%Part D<11 patientsMusculoskeletal
8.4%Central alpha-2 Adrenergic Agonist4.5%Tizanidine Hcl100%Part D<11 patientsMuscle Relaxant3.9%Cyclobenzaprine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rituximab for prevention of strokes in cerebral rheumatoid vasculitis
Clinical Neurology and Neurosurgery
2022 - Impact of the COVID-19 Pandemic on Acute Stroke Care, Time Metrics, Outcomes, and Racial Disparities in a Southeast Michigan Health System
Journal of Stroke and Cerebrovascular Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”